IN2014MN02467A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02467A IN2014MN02467A IN2467MUN2014A IN2014MN02467A IN 2014MN02467 A IN2014MN02467 A IN 2014MN02467A IN 2467MUN2014 A IN2467MUN2014 A IN 2467MUN2014A IN 2014MN02467 A IN2014MN02467 A IN 2014MN02467A
- Authority
- IN
- India
- Prior art keywords
- tetrahydrothieno
- thiazol
- dioxo
- pyrimidin
- difluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The present disclosure is directed to salts of N {4 [2 4 difluoro 3 (trifluoromethyl)phenyl] 1 3 thiazol 2 yl} 2 (1 3 dimethyl 2 4 dioxo 1 2 3 4 tetrahydrothieno[2 3 d]pyrimidin 5 yl)acetamide and process for the preparation thereof (formula II).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2467MUN2014 IN2014MN02467A (en) | 2012-06-08 | 2013-06-08 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1687MU2012 | 2012-06-08 | ||
US201261665282P | 2012-06-27 | 2012-06-27 | |
IN3519MU2012 | 2012-12-13 | ||
US201261748016P | 2012-12-31 | 2012-12-31 | |
IN2467MUN2014 IN2014MN02467A (en) | 2012-06-08 | 2013-06-08 | |
PCT/IB2013/054703 WO2013183035A2 (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02467A true IN2014MN02467A (en) | 2015-07-10 |
Family
ID=54193746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2467MUN2014 IN2014MN02467A (en) | 2012-06-08 | 2013-06-08 |
Country Status (22)
Country | Link |
---|---|
US (1) | US9458173B2 (en) |
EP (1) | EP2858999B1 (en) |
JP (1) | JP5989900B2 (en) |
KR (1) | KR20150015488A (en) |
CN (1) | CN104350058A (en) |
AP (1) | AP3546A (en) |
AU (1) | AU2013273118B2 (en) |
BR (1) | BR112014029155A2 (en) |
CA (1) | CA2873570C (en) |
CL (1) | CL2014003317A1 (en) |
EA (1) | EA031334B1 (en) |
HK (1) | HK1207643A1 (en) |
IL (1) | IL236084A0 (en) |
IN (1) | IN2014MN02467A (en) |
MX (1) | MX354014B (en) |
MY (1) | MY165622A (en) |
NZ (1) | NZ701721A (en) |
PE (1) | PE20142306A1 (en) |
PH (1) | PH12014502685A1 (en) |
SG (1) | SG11201408093PA (en) |
WO (1) | WO2013183035A2 (en) |
ZA (1) | ZA201500082B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR091279A1 (en) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE |
ES2624223T3 (en) | 2012-06-08 | 2017-07-13 | Gilead Sciences, Inc. | Macrocyclic inhibitors of flaviviridae viruses |
CA2912578A1 (en) | 2013-06-20 | 2014-12-24 | Glenmark Pharmaceuticals S.A. | Nanoparticulate formulation comprising a trpa1 antagonist |
WO2016023832A1 (en) * | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
US20190175599A1 (en) * | 2014-09-16 | 2019-06-13 | Glemark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
TW202321229A (en) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | Fungicidal substituted heterocycles |
CN114671875A (en) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | Novel dihydropyrimidine compound, isomer or salt, and preparation method and application thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2248231A1 (en) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-AMINOISOTHIAZOLO SQUARE BRACKET ON 3.4 SQUARE BRACKET FOR PYRIMIDINE |
SE9701398D0 (en) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
ES2193839B1 (en) * | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | NEW DERIVATIVES OF 6-PHENYLDIHYDROPIRROLPIRIMIDINDIONA. |
AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
US6890923B2 (en) | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
US7465581B2 (en) | 2002-12-18 | 2008-12-16 | The Scripps Research Institute | ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons |
CA2536313A1 (en) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | Fused pyrimidine derivative and use thereof |
WO2005077959A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Pth agonists |
US20070196866A1 (en) | 2004-03-13 | 2007-08-23 | Irm Llc | Modulators of ion channel trpa1 |
WO2006083005A1 (en) | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | Fused pyrimidine derivative and used thereof |
US20070032531A1 (en) | 2005-08-04 | 2007-02-08 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
US20070105920A1 (en) | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
AU2006327181A1 (en) | 2005-12-22 | 2007-06-28 | Hydra Biosciences, Inc. | TRPA1 inhibitors for treating pain |
TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
CN101454318A (en) * | 2006-03-22 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | Pyridopyrimidine derivatives and their use as pde4 inhibitors |
JP2011201776A (en) | 2008-07-23 | 2011-10-13 | Mochida Pharmaceut Co Ltd | Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolinon-5-yl)acetamide derivative |
CL2008000252A1 (en) | 2007-01-29 | 2008-03-14 | Xenon Pharmaceuticals Inc | COMPOUNDS DERIVED FROM QUINAZOLINONA OR PIRIMIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT DISEASES MEDIATED BY CALCIUM CHANNELS, SUCH AS PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIR |
SI3184527T1 (en) | 2007-06-22 | 2020-03-31 | Eli Lilly And Company | 2,6-dioxo,-2,3-dihydro-1h-purine compounds useful for treating disorders related to the activity of the trpa1 channel |
US7951814B2 (en) * | 2008-06-17 | 2011-05-31 | Glenmark Pharmaceuticals, S.A. | Quinazolinedione derivatives as TRPA1 modulators |
WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
DK2411397T3 (en) | 2009-03-23 | 2013-08-05 | Glenmark Pharmaceuticals Sa | Isothiazole-pyrimidinedione derivatives as modulators of TRPA1 |
ES2456515T3 (en) | 2009-03-23 | 2014-04-22 | Glenmark Pharmaceuticals S.A. | Fused pyrimidinedione derivatives as modulators of TRPA1 |
US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
PT2411395E (en) | 2009-03-23 | 2013-06-06 | Glenmark Pharmaceuticals Sa | Furopyrimidinedione derivatives as trpa1 modulators |
AP3391A (en) | 2010-12-20 | 2015-08-31 | Glenmark Pharmaceuticals Sa | 2-Amino-4-arylthiazole compounds as TROA1 antagonists |
-
2013
- 2013-06-08 CA CA2873570A patent/CA2873570C/en active Active
- 2013-06-08 AU AU2013273118A patent/AU2013273118B2/en not_active Ceased
- 2013-06-08 EA EA201492054A patent/EA031334B1/en unknown
- 2013-06-08 KR KR1020147033855A patent/KR20150015488A/en active IP Right Grant
- 2013-06-08 NZ NZ701721A patent/NZ701721A/en not_active IP Right Cessation
- 2013-06-08 CN CN201380030184.XA patent/CN104350058A/en active Pending
- 2013-06-08 SG SG11201408093PA patent/SG11201408093PA/en unknown
- 2013-06-08 MX MX2014014482A patent/MX354014B/en active IP Right Grant
- 2013-06-08 MY MYPI2014003389A patent/MY165622A/en unknown
- 2013-06-08 AP AP2014008076A patent/AP3546A/en active
- 2013-06-08 WO PCT/IB2013/054703 patent/WO2013183035A2/en active Application Filing
- 2013-06-08 BR BR112014029155A patent/BR112014029155A2/en not_active Application Discontinuation
- 2013-06-08 EP EP13742279.6A patent/EP2858999B1/en active Active
- 2013-06-08 PE PE2014002226A patent/PE20142306A1/en not_active Application Discontinuation
- 2013-06-08 US US14/402,608 patent/US9458173B2/en active Active
- 2013-06-08 JP JP2015515642A patent/JP5989900B2/en not_active Expired - Fee Related
- 2013-06-08 IN IN2467MUN2014 patent/IN2014MN02467A/en unknown
-
2014
- 2014-12-02 PH PH12014502685A patent/PH12014502685A1/en unknown
- 2014-12-04 CL CL2014003317A patent/CL2014003317A1/en unknown
- 2014-12-04 IL IL236084A patent/IL236084A0/en unknown
-
2015
- 2015-01-07 ZA ZA2015/00082A patent/ZA201500082B/en unknown
- 2015-08-27 HK HK15108333.2A patent/HK1207643A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2858999A2 (en) | 2015-04-15 |
EP2858999B1 (en) | 2017-05-10 |
IL236084A0 (en) | 2015-02-01 |
PH12014502685B1 (en) | 2015-01-26 |
US20150111038A1 (en) | 2015-04-23 |
ZA201500082B (en) | 2015-12-23 |
WO2013183035A2 (en) | 2013-12-12 |
AP2014008076A0 (en) | 2014-11-30 |
HK1207643A1 (en) | 2016-02-05 |
BR112014029155A2 (en) | 2017-06-27 |
CL2014003317A1 (en) | 2015-02-13 |
US9458173B2 (en) | 2016-10-04 |
CA2873570A1 (en) | 2013-12-12 |
MX354014B (en) | 2018-02-08 |
MY165622A (en) | 2018-04-18 |
WO2013183035A3 (en) | 2014-02-27 |
AU2013273118B2 (en) | 2015-11-05 |
JP2015520183A (en) | 2015-07-16 |
AP3546A (en) | 2016-01-14 |
CN104350058A (en) | 2015-02-11 |
KR20150015488A (en) | 2015-02-10 |
SG11201408093PA (en) | 2015-01-29 |
JP5989900B2 (en) | 2016-09-07 |
PE20142306A1 (en) | 2015-01-16 |
EA201492054A1 (en) | 2016-08-31 |
NZ701721A (en) | 2016-03-31 |
PH12014502685A1 (en) | 2015-01-26 |
EA031334B1 (en) | 2018-12-28 |
MX2014014482A (en) | 2015-06-05 |
AU2013273118A1 (en) | 2014-11-27 |
CA2873570C (en) | 2016-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02467A (en) | ||
PH12015501328A1 (en) | Meglumine salt of 6-flouro-3-hydroxy-2-pyrazine carboxamide | |
PH12015501649A1 (en) | Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide | |
CO6831982A2 (en) | Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors | |
MX2019009100A (en) | Novel triazolo[4,5-d]pyrimidine derivatives. | |
CR20140132A (en) | PIRROLOPIRIMIDINE AND PURINE DERIVATIVES | |
CR20130470A (en) | QUINASE INHIBITORS RELATED TO PIRROLO [2,3-d] PYRIMIDINE THROMPOMIOSINE | |
MX2012012530A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives. | |
MY171831A (en) | Novel fused pyrimidine compound or salt thereof | |
IL228239A0 (en) | 3,4-dihydro--pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace) | |
MX2013015308A (en) | Proteasome inhibitors and processes for their preparation, purification and use. | |
NZ749557A (en) | 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides | |
NZ701933A (en) | Phenoxyethyl piperidine compounds | |
EA201591105A1 (en) | PYRIMIDO [4,5-b] QUINOLIN-4,5- (3H, 10H) -DIONES AS SUPRESSORS NONSENS MUTATIONS | |
PH12015500363A1 (en) | Prodrugs of amino quinazoline kinase inhibitor | |
PH12015502409B1 (en) | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists | |
MX346678B (en) | Immunologically useful arginine salts. | |
MX2013015436A (en) | Amido-pyridyl ether compounds and compositions and their use against parasites. | |
JO3063B1 (en) | Novel compound and methods for its production | |
GEP20146183B (en) | Process for preparation of l-arginine salt of perindopril | |
EA201590315A1 (en) | MEANS AND METHOD OF TREATMENT OF SOLID TUMORS | |
WO2014160177A3 (en) | Quinazoline inhibitors of pi3k | |
CR20140545A (en) | PIPERAZINO [1,2-A] INDOL-1-ONAS AND [1,4] DIAZEPINO [1,2-A] INDOL-1-ONA | |
MY164134A (en) | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring | |
MX358151B (en) | Sitaxsentan derivative. |